Literature DB >> 10543448

Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.

H Kolkenbrock1, L Essers, N Ulbrich, H Will.   

Abstract

A C-terminal truncated form of membrane-type 4 matrix metalloproteinase (MT4-MMP; MMP 17), lacking the hemopexin-like and transmembrane domain, was expressed in Escherichia coli. The catalytic domain was produced by tryptic activation of the recombinant proenzyme and proved to be catalytically active towards the fluorogenic substrate for matrix metalloproteinases (7-methoxycoumarin-4-yl) acetyl-Pro-Leu-Gly-Leu(3-(2,4-dinitrophenyl)-L-2,3-diaminopro-p ionyl)-Ala-Arg-NH2. In contrast to the other three MT-MMPs (MT1-, MT2-, and MT3-MMP), the catalytic domain of MT4-MMP does not activate progelatinase A, nor does it hydrolyze one of the offered extracellular matrix (ECM) proteins, such as collagen types I, II, III, IV, and V, gelatin, fibronectin, laminin or decorin. TIMP-1, a poor inhibitor of MT1-, MT2- and MT3-MMP, suppresses MT4-MMP activity effectively. The progelatinase A/TIMP-2 complex that usually reacts like TIMP-2 also inhibits MT4-MMP. TIMP-2, a strong inhibitor of other MT-MMPS, inhibits MT4-MMP at low concentrations. With increasing TIMP-2 concentration, however, activity passes through a minimum and then increases until at high TIMP-2 concentration the activity is the same as in the absence of TIMP-2. TIMP-1 or the progelatinase A/TIMP-2 complex do not prevent reactivation of MT4-MMP catalytic domain at high TIMP-2 concentrations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543448     DOI: 10.1515/BC.1999.137

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  11 in total

Review 1.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

2.  Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.

Authors:  T Shimada; H Nakamura; K Yamashita; R Kawata; Y Murakami; N Fujimoto; H Sato; M Seiki; Y Okada
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 3.  MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer.

Authors:  Anjum Sohail; Qing Sun; Huiren Zhao; M Margarida Bernardo; Jin-Ah Cho; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

4.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

5.  Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.

Authors:  Asmaa B Hamze; Shuo Wei; Harinath Bahudhanapati; Smitha Kota; K Ravi Acharya; Keith Brew
Journal:  Protein Sci       Date:  2007-07-27       Impact factor: 6.725

Review 6.  Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization.

Authors:  Caroline A Owen
Journal:  Int J Biochem Cell Biol       Date:  2008-01-31       Impact factor: 5.085

7.  Membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture.

Authors:  Vincent Chabottaux; Stéphanie Ricaud; Laurent Host; Silvia Blacher; Alexandra Paye; Marc Thiry; Anikitos Garofalakis; Carine Pestourie; Karine Gombert; Françoise Bruyere; Daniel Lewandowsky; Bertrand Tavitian; Jean-Michel Foidart; Frédéric Duconge; Agnès Noel
Journal:  J Cell Mol Med       Date:  2009-05-10       Impact factor: 5.310

8.  Developmental expression of membrane type 4-matrix metalloproteinase (Mt4-mmp/Mmp17) in the mouse embryo.

Authors:  María José Blanco; Iván Rodríguez-Martín; Ana I R Learte; Cristina Clemente; María Gregoria Montalvo; Motoharu Seiki; Alicia G Arroyo; Cristina Sánchez-Camacho
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

9.  Kallikrein-Related Peptidase 14 Activates Zymogens of Membrane Type Matrix Metalloproteinases (MT-MMPs)-A CleavEx Based Analysis.

Authors:  Katherine Falkowski; Ewa Bielecka; Ida B Thøgersen; Oliwia Bocheńska; Karolina Płaza; Magdalena Kalińska; Laura Sąsiadek; Małgorzata Magoch; Aleksandra Pęcak; Magdalena Wiśniewska; Natalia Gruba; Magdalena Wysocka; Anna Wojtysiak; Magdalena Brzezińska-Bodal; Kamila Sychowska; Anastasija Pejkovska; Maren Rehders; Georgina Butler; Christopher M Overall; Klaudia Brix; Grzegorz Dubin; Adam Lesner; Andrzej Kozik; Jan J Enghild; Jan Potempa; Tomasz Kantyka
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

10.  Mmp17b is essential for proper neural crest cell migration in vivo.

Authors:  Noah R Leigh; Marcus-Oliver Schupp; Keguo Li; Vakeel Padmanabhan; Adam Gastonguay; Ling Wang; Chang Z Chun; George A Wilkinson; Ramani Ramchandran
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.